NAA10 and breast cancer: Combined analyses indicated that ARD1‐positive/MMP‐9‐negative patients exhibited the best OS and DFS, and multifactorial analysis confirmed the significant impact of ARD1 and MMP‐9 expression on breast cancer prognosis [37].